InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
pUNO-mcs | Human rhinovirus promotes STING trafficking to replication organelles to prom... | 2022 | Nat Commun | Triantafilou M. et al. | DOI: 10.1038/s41467-022-28745-3 |
Anti-Flagellin | Salmonella Typhimurium O-antigen and VisP play an important role in swarming ... | 2022 | Braz J Microbiol. | Manieri F.Z. & Moreira C.G. | DOI: 10.1007/s42770-022-00701-9 |
HKSA | BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell ... | 2022 | Acta Neuropathol | Li R. et al. | DOI: 10.1007/s00401-022-02411-w |
ODN 2006 (ODN 7909) | BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell ... | 2022 | Acta Neuropathol | Li R. et al. | DOI: 10.1007/s00401-022-02411-w |
Human TLR9 Reporter HEK293 Cells | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ Null1 Cells | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ hTLR3 | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
Zeocin® | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ hTLR4 | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ hTLR2 | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
Blasticidin | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
QUANTI-Blue™ | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ hTLR5 | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
HEK-Blue™ Selection | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
Hygromycin B Gold | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
Normocin™ - Antimicrobial Reagent | Modulation of outer membrane vesicle-based immune responses by cathelicidins. | 2022 | Vaccine | Balhuizen M.D. et al. | DOI: 10.1016/j.vaccine.2022.03.015 |
QUANTI-Luc™ | A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... | 2022 | J Control Release | Carson C.S. et al. | DOI: 10.1016/j.jconrel.2022.03.020 |
THP1-Dual™ Cells | A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... | 2022 | J Control Release | Carson C.S. et al. | DOI: 10.1016/j.jconrel.2022.03.020 |
QUANTI-Blue™ | A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... | 2022 | J Control Release | Carson C.S. et al. | DOI: 10.1016/j.jconrel.2022.03.020 |
Poly(I:C) (HMW) VacciGrade™ | The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual m... | 2022 | J Immunother Cancer | Sum E. et al. | DOI: 10.1136/jitc-2021-003264 |